Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC with Mitomycin C in Locally Advanced Colorectal Carcinoma
NCT02614534Phase 3Unknown
- Sponsor
- Maimónides Institute of Biomedical Research of Córdoba
- Start
- Nov 2015
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c in colorectal carcinoma (CRC), sponsored by Maimónides Institute of Biomedical Research of Córdoba. Status: unknown.
02
Drugs
mitomycin c
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT02614534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02614534.